Intrinsic Value of S&P & Nasdaq Contact Us

Cue Health Inc. HLTH NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
45/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
+18333.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cue Health Inc. (HLTH) .

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+18333.2%).
  • Analyst consensus target $8.00 (+18333.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 45/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
45/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — HLTH

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.09
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.44
Book Value / Share$0.00
Revenue / Share$0.46
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$8.00 (+18333.2%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.14 $6.63M $-21.07M -317.9%
2020 $-0.33 $22.95M $-48.38M -210.8%
2021 $0.23 $618.11M $86.42M 14%
2022 $-1.31 $483.48M $-194.06M -40.1%
2023 $-2.44 $70.94M $-373.46M -526.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message